Ancient drug could save NHS millions each year when treating older patients with heart conditions

A 240-year-old drug called digoxin could save the National Health Service (NHS) at least £100 million each year when treating older patients with atrial fibrillation and heart failure.

Scoop: Merck scraps PhII trials of Alzheimer’s and depression small molecule after liver toxicity observations

Merck has ended work on two separate Phase II studies of its small molecule for treatment-resistant depression and mild-to-moderate Alzheimer’s disease, the pharma confirmed to

October 26, 2023

Seasonal peaks in teen suicidality occur in April and October, research shows

The incidences of teen suicidality including self-harm, suicidal ideation, and suicide attempts increased nationally between 2016 and 2021; were at seasonal high peaks in April

July 19, 2023

Guardian molecule found to prevent cancer cells from changing identity

A guardian molecule ensures that liver cells do not lose their identity. This has been discovered by researchers from the German Cancer Research Center (DKFZ),

February 13, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.